Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Genetic variants in the fibroblast growth factor pathway as potential markers of ovarian cancer risk, therapeutic response, and clinical outcome.

Clinical chemistry - 1 Jan 2014

Meng Qing H, Xu Enping, Hildebrandt Michelle A T, Liang Dong, Lu Karen, Ye Yuanqing, Wagar Elizabeth A, Wu Xifeng

Abstract excerpt

BACKGROUND: The fibroblast growth factor (FGF) and FGF receptor (FGFR) axis plays a critical role in tumorigenesis, but little is known of its influence in ovarian cancer. We sought to determine the association of genetic variants in the FGF pathway with risk, therapeutic response, and survival of patients with ovarian cancer. METHODS: We matched 339 non-Hispanic white ovarian cancer cases with 349 healthy...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antineoplastic Agents
Share to Biomarkers, Tumor

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Fibroblast Growth Factor-23

Share to Fibroblast Growth Factors

Share to Ovarian Neoplasms

Share to Reference Standards

Share to Signal Transduction

Share to Treatment Outcome

Source

Open in PubMed Open full text

Identifiers

PMID: 24146310
DOI: 10.1373/clinchem.2013.211490
PMCID: PMC4437198

Genes

FGF23
FGF1
FGF18
FGF2
FGF5
FGF7

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Genetic variants in the fibroblast growth factor pathway as potential markers of ovarian cancer risk, therapeutic response, and clinical outcome.PMID 24146310Read ↗

Genome-wide Analysis Identifies Novel Loci Associated with Ovarian Cancer Outcomes: Findings from the Ovarian Cancer Association Consortium.Semantic proximity Read ↗

Ovarian cancer susceptibility alleles and risk of ovarian cancer in BRCA1 and BRCA2 mutation carriers.Semantic proximity Read ↗

Common variants at 19p13 are associated with susceptibility to ovarian cancer.Semantic proximity Read ↗

Identification of KIF23 as a prognostic signature for ovarian cancer based on large scale samples and clinical validationSemantic proximity Read ↗

Fibroblast growth factor receptor 4 gene (FGFR4) 388Arg allele predicts prolonged survival and platinum sensitivity in advanced ovarian cancer.Semantic proximity Read ↗

A genome-wide association study identifies susceptibility loci for ovarian cancer at 2q31 and 8q24.Semantic proximity Read ↗

Oncogenic pathway landscape of ovarian cancer and correlation with clinical prognosis.Semantic proximity Read ↗

Inherited determinants of ovarian cancer survival.Semantic proximity Read ↗

Genome-wide association study identifies new susceptibility loci for epithelial ovarian cancer in Han Chinese women.Semantic proximity Read ↗

Cell cycle genes and ovarian cancer susceptibility: a tagSNP analysis.Semantic proximity Read ↗

Genome-wide association study in BRCA1 mutation carriers identifies novel loci associated with breast and ovarian cancer risk.Semantic proximity Read ↗

Genetic variants in matrix metalloproteinase genes as disposition factors for ovarian cancer risk, survival, and clinical outcome.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.